Derleme
BibTex RIS Kaynak Göster

Mide Kanseri, Mide Kanseri Taramaları ve Mide Kanserinden Korunma

Yıl 2012, Cilt: 12 Sayı: 4, 195 - 198, 01.04.2012

Öz

Özet: 

Mide kanseri ülkemizde sıklığı artan kanser türlerindendir ve bu konuya önem verilmesi gereklidir. Bu nedenle bu makalede mide kanseri ve ilişkili faktörler, korunma ve tarama yöntemleri hakkında genel bilgi vermek amaçlanmıştır.

Kaynakça

  • 1. Tuncer AM. Türkiye’de kanser kontrolü TC Sağlık Bakanlığı Kanserle Savaş Daire Başkanlığı http://onkofar. com/vImages/pdfler/2009_Turkiyedekanserkontrolu. pdf#page=20 (siteye giriş tarihi: 14.11.2012)
  • 2. Hosseini NS, Mousavinasab SN, Moghimi MH et al. Mide kanserinde semptomların başlangıcından cerrahi tedaviye kadar geçen gecikme süresi: Bir İran çalışması The Turkish Journal of Gastroenterology2007, Volume 18, No 2, Page(s) 77-81
  • 3. Wayman J, Forman D, Griffin SM. Monitoring the changing pattern of esophagogastric cancer: data from a UK regional cancer registry. Cancer Causes Control. 2001; 12: 943-49
  • 4. Terry MB, Gaudet MM, Gammon MD. The epidemiology of gastric cancer. Semin Radiat Oncol. 2002; 12: 111-27.
  • 5. WHO (World Health Organisation Report, Cancer Fact sheet N°297 http://www.who.int/mediacentre/factsheets/ fs297/en/ (Siteye giriş tarihi 10/10/2012)
  • 6. Yalçın B, Zengin N, Aydın F, İlhan M, Işıkdoğan A, Demir G ve ark.The clinical and pathological features of patients with gastric cancer in Turkey: A Turkish Oncology Group Study. Turkish Journal of Cancer Volume 36, No.3, 2006 s:108-115
  • 7. National Cancer Institute. Surveillance, epidemiology and end results: incidance, stomach cancer. http://seer.cancer.gov/ statfacts/html/stomach.html (siteye giriş tarihi: 10/10/2012)
  • 8. Kranenbarg EK, vande Velde CJ. Gastric cancer in the elderly. Eur J Surg Oncol. 1998; 24: 384-90.
  • 9. Metlin C. Epidemiologic studies in gastric adenocarcinoma. In Douglass HO(ed). Gastric cancer. New York: Churchill Livingstone 1988; 1-25.
  • 10. TC Sağlık Bakanlığı Kanser İstatistikleri. http://www. saglik.gov.tr/TR/belge/1-7179/eski2yeni.html (Siteye giriş tarihi: 10/10/2012)
  • 11. Gürel S. Mide kanserlerinin genel özellikleri. Güncel Gastroenteroloji 1999; 3: 392-402.
  • 12. Xu G, Song P, Reed PI. The relationship between gastric mucosal changes and nitrate intake via drinking water in a high-risk population for gastric cancer in Moping county, China. Eur J Cancer Prev. 1992; 1: 437-43.
  • 13. Kneller RW, McLaughlin JK, Bjelke E, et al. A cohort study of stomach cancer in a high-risk American Population. Cancer. 1991; 68: 672-8.
  • 14. Cocco P, Ward MH, Buiatti E. Occupational risk factors for gastric cancer: an Overview. Epidemiol Rev. 1996; 18: 218-34.
  • 15. Correa P. Human gastric carsinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992; 52: 6735-40.
  • 16. Viste A, Eide GE, Halvorsen K, et al. The prognostic value of Lauren’s histopathological classification system and ABO blood groups in patients with stomach carcinoma. Eur J Surg Oncol. 1986; 12: 135-41.
  • 17. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986; 8: 1-27.
  • 18. Adachi Y, Mori M, Enjoji M, et al. Microvascular architecture of early gastric carcinoma. Microvascular-histopathologic correlates. Cancer. 1993; 72: 32-6.
  • 19. Karaayvaz M, Kocaoğlu H, Demirci S. Mide Kanserleri, In: ‘Klinik Cerrahi Onkoloji’ Ed. Ünal A, Özkan Matbaacılık, Ankara, 1997; 468-478.
  • 20. Chapman AH . The stomach and duodenum . In . Sutton D ( Eds ) . Textbook of Radyology and Imaging . 6 th ed . London : Churchill Livingstone ; 2000 . p . 829-61
  • 21. Munoz N. Is Helicobacter pylori a cause of gastric cancer? An appraisal of the seroepidemiological evidence. Cancer Epidemiol Biomarkers Prev. 1994; 3: 445-51.
  • 22. Korenaga D, Haraguchi M, Okamura T,et al. DNA ploidy and tumor invasion in human gastric cancer. Histopathologic differentiation. Arch Surg. 1989; 124: 314-8.
  • 23. Ohta H, Noguchi Y, Takagi K, et al. Early gastric carcinoma with special reference to macroscopic classification. Cancer. 1987; 60: 1099-106.
  • 24. Wilson SR . The Gastrointestinal Tract. In : Rumach CM , Wilson SR , Charboneu JW ( Eds). Diagnostic Ultrasound vol 1 , Missouri : Mosby ; 1998 . p . 280-5 .
  • 25. Lim JH, Ko YT, Lee DH. Transabdominal US staging of gastric cancer. Abdom Imaging. 1994; 19: 527-31.
  • 26. egura JM, Olveira A, Conde P, et al. Hydrogastric sonography in the p reoperative staging of gastric cancer. J Clin Ultrasound. 1999; 27: 499-504.
  • 27. Botet JF, Lightdale CJ, Zauber AG, et al. Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology. 1991; 181: 426-32.
  • 28. Tunaci M. Carcinoma of stomach and duodenum: radiologic diagnosis and staging. Eur J Radiol. 2002; 42: 181 -92.
  • 29. Hada M, Hihara T, Kakishita M. Computed tomography in gastric carcinoma: thickness of gastric wall and infiltration to serosa surface. Radiat Med. 1984; 2: 27-30.
  • 30. Gaitini D, Kleinhaus U, Munichor M, et al. Villous tumors of the stomach. Gastrointest Radiol. 1988; 13: 105-8.
  • 31. Motohara T, Semelka RC. MRI in staging of gastric cancer. Abdom Imaging. 2002; 27: 376-83.
  • 32. Giovagnoni A, Fabbri A, Maccioni F. Oral contrast agents in MRI of the gastrointestinal tract. Abdom Imaging. 2002; 27: 367-75.
  • 33. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784–89.
  • 34. Yamagata H, Kiyohara Y, Aoyagi K, et al. Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population. Arch Intern Med 2000; 160: 1962–68
  • 35. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, Gotoda T, Lin JT, You WC, Ng EK, Sung JJ; Asia Pacific Working Group on Gastric CancerScreening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008 Mar;9(3):279-87. Review
  • 36. Goh KL, Cheah PL, Md N, Quek KF, Parasakthi N. Ethnicity and H. pylori as risk factors for gastric cancer in Malaysia: a prospective case control study. Am J Gastroenterol 2007; 102: 40–45.
  • 37. Sung NY, Choi KS, Park EC, et al. Smoking, alcohol and gastric cancer risk in Korean men: the National Health Insurance Corporation Study. Br J Cancer 2007; 97: 700–04
  • 38. Ji BT, Chow WH, Yang G, et al. Dietary habits and stomach cancer in Shanghai, China. Int J Cancer 1998; 76: 659–64.
  • 39. Kim HJ, Chang WK, Kim MK, et al. Dietary factors and gastric cancer in Korea: a case-control study. Int J Cancer 2002;97: 531–35.
  • 40. Shikata K, Kiyohara Y, Kudo M, et al. A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer 2006; 119: 196–201

Gastric Cancer, Screening And Prevention Methods

Yıl 2012, Cilt: 12 Sayı: 4, 195 - 198, 01.04.2012

Öz

Gastric cancer’s incidence is rising in our country and attention should be given to this topic. For this reason; the
aim of this article was to give information about gastric
cancer together with prevention and screening methods.

Kaynakça

  • 1. Tuncer AM. Türkiye’de kanser kontrolü TC Sağlık Bakanlığı Kanserle Savaş Daire Başkanlığı http://onkofar. com/vImages/pdfler/2009_Turkiyedekanserkontrolu. pdf#page=20 (siteye giriş tarihi: 14.11.2012)
  • 2. Hosseini NS, Mousavinasab SN, Moghimi MH et al. Mide kanserinde semptomların başlangıcından cerrahi tedaviye kadar geçen gecikme süresi: Bir İran çalışması The Turkish Journal of Gastroenterology2007, Volume 18, No 2, Page(s) 77-81
  • 3. Wayman J, Forman D, Griffin SM. Monitoring the changing pattern of esophagogastric cancer: data from a UK regional cancer registry. Cancer Causes Control. 2001; 12: 943-49
  • 4. Terry MB, Gaudet MM, Gammon MD. The epidemiology of gastric cancer. Semin Radiat Oncol. 2002; 12: 111-27.
  • 5. WHO (World Health Organisation Report, Cancer Fact sheet N°297 http://www.who.int/mediacentre/factsheets/ fs297/en/ (Siteye giriş tarihi 10/10/2012)
  • 6. Yalçın B, Zengin N, Aydın F, İlhan M, Işıkdoğan A, Demir G ve ark.The clinical and pathological features of patients with gastric cancer in Turkey: A Turkish Oncology Group Study. Turkish Journal of Cancer Volume 36, No.3, 2006 s:108-115
  • 7. National Cancer Institute. Surveillance, epidemiology and end results: incidance, stomach cancer. http://seer.cancer.gov/ statfacts/html/stomach.html (siteye giriş tarihi: 10/10/2012)
  • 8. Kranenbarg EK, vande Velde CJ. Gastric cancer in the elderly. Eur J Surg Oncol. 1998; 24: 384-90.
  • 9. Metlin C. Epidemiologic studies in gastric adenocarcinoma. In Douglass HO(ed). Gastric cancer. New York: Churchill Livingstone 1988; 1-25.
  • 10. TC Sağlık Bakanlığı Kanser İstatistikleri. http://www. saglik.gov.tr/TR/belge/1-7179/eski2yeni.html (Siteye giriş tarihi: 10/10/2012)
  • 11. Gürel S. Mide kanserlerinin genel özellikleri. Güncel Gastroenteroloji 1999; 3: 392-402.
  • 12. Xu G, Song P, Reed PI. The relationship between gastric mucosal changes and nitrate intake via drinking water in a high-risk population for gastric cancer in Moping county, China. Eur J Cancer Prev. 1992; 1: 437-43.
  • 13. Kneller RW, McLaughlin JK, Bjelke E, et al. A cohort study of stomach cancer in a high-risk American Population. Cancer. 1991; 68: 672-8.
  • 14. Cocco P, Ward MH, Buiatti E. Occupational risk factors for gastric cancer: an Overview. Epidemiol Rev. 1996; 18: 218-34.
  • 15. Correa P. Human gastric carsinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992; 52: 6735-40.
  • 16. Viste A, Eide GE, Halvorsen K, et al. The prognostic value of Lauren’s histopathological classification system and ABO blood groups in patients with stomach carcinoma. Eur J Surg Oncol. 1986; 12: 135-41.
  • 17. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986; 8: 1-27.
  • 18. Adachi Y, Mori M, Enjoji M, et al. Microvascular architecture of early gastric carcinoma. Microvascular-histopathologic correlates. Cancer. 1993; 72: 32-6.
  • 19. Karaayvaz M, Kocaoğlu H, Demirci S. Mide Kanserleri, In: ‘Klinik Cerrahi Onkoloji’ Ed. Ünal A, Özkan Matbaacılık, Ankara, 1997; 468-478.
  • 20. Chapman AH . The stomach and duodenum . In . Sutton D ( Eds ) . Textbook of Radyology and Imaging . 6 th ed . London : Churchill Livingstone ; 2000 . p . 829-61
  • 21. Munoz N. Is Helicobacter pylori a cause of gastric cancer? An appraisal of the seroepidemiological evidence. Cancer Epidemiol Biomarkers Prev. 1994; 3: 445-51.
  • 22. Korenaga D, Haraguchi M, Okamura T,et al. DNA ploidy and tumor invasion in human gastric cancer. Histopathologic differentiation. Arch Surg. 1989; 124: 314-8.
  • 23. Ohta H, Noguchi Y, Takagi K, et al. Early gastric carcinoma with special reference to macroscopic classification. Cancer. 1987; 60: 1099-106.
  • 24. Wilson SR . The Gastrointestinal Tract. In : Rumach CM , Wilson SR , Charboneu JW ( Eds). Diagnostic Ultrasound vol 1 , Missouri : Mosby ; 1998 . p . 280-5 .
  • 25. Lim JH, Ko YT, Lee DH. Transabdominal US staging of gastric cancer. Abdom Imaging. 1994; 19: 527-31.
  • 26. egura JM, Olveira A, Conde P, et al. Hydrogastric sonography in the p reoperative staging of gastric cancer. J Clin Ultrasound. 1999; 27: 499-504.
  • 27. Botet JF, Lightdale CJ, Zauber AG, et al. Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology. 1991; 181: 426-32.
  • 28. Tunaci M. Carcinoma of stomach and duodenum: radiologic diagnosis and staging. Eur J Radiol. 2002; 42: 181 -92.
  • 29. Hada M, Hihara T, Kakishita M. Computed tomography in gastric carcinoma: thickness of gastric wall and infiltration to serosa surface. Radiat Med. 1984; 2: 27-30.
  • 30. Gaitini D, Kleinhaus U, Munichor M, et al. Villous tumors of the stomach. Gastrointest Radiol. 1988; 13: 105-8.
  • 31. Motohara T, Semelka RC. MRI in staging of gastric cancer. Abdom Imaging. 2002; 27: 376-83.
  • 32. Giovagnoni A, Fabbri A, Maccioni F. Oral contrast agents in MRI of the gastrointestinal tract. Abdom Imaging. 2002; 27: 367-75.
  • 33. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784–89.
  • 34. Yamagata H, Kiyohara Y, Aoyagi K, et al. Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population. Arch Intern Med 2000; 160: 1962–68
  • 35. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, Gotoda T, Lin JT, You WC, Ng EK, Sung JJ; Asia Pacific Working Group on Gastric CancerScreening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008 Mar;9(3):279-87. Review
  • 36. Goh KL, Cheah PL, Md N, Quek KF, Parasakthi N. Ethnicity and H. pylori as risk factors for gastric cancer in Malaysia: a prospective case control study. Am J Gastroenterol 2007; 102: 40–45.
  • 37. Sung NY, Choi KS, Park EC, et al. Smoking, alcohol and gastric cancer risk in Korean men: the National Health Insurance Corporation Study. Br J Cancer 2007; 97: 700–04
  • 38. Ji BT, Chow WH, Yang G, et al. Dietary habits and stomach cancer in Shanghai, China. Int J Cancer 1998; 76: 659–64.
  • 39. Kim HJ, Chang WK, Kim MK, et al. Dietary factors and gastric cancer in Korea: a case-control study. Int J Cancer 2002;97: 531–35.
  • 40. Shikata K, Kiyohara Y, Kudo M, et al. A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer 2006; 119: 196–201
Toplam 40 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Derlemeler
Yazarlar

Mehmet Alacalı Bu kişi benim

Yayımlanma Tarihi 1 Nisan 2012
Yayımlandığı Sayı Yıl 2012 Cilt: 12 Sayı: 4

Kaynak Göster

APA Alacalı, M. (2012). Mide Kanseri, Mide Kanseri Taramaları ve Mide Kanserinden Korunma. Ankara Medical Journal, 12(4), 195-198.
AMA Alacalı M. Mide Kanseri, Mide Kanseri Taramaları ve Mide Kanserinden Korunma. Ankara Med J. Nisan 2012;12(4):195-198.
Chicago Alacalı, Mehmet. “Mide Kanseri, Mide Kanseri Taramaları Ve Mide Kanserinden Korunma”. Ankara Medical Journal 12, sy. 4 (Nisan 2012): 195-98.
EndNote Alacalı M (01 Nisan 2012) Mide Kanseri, Mide Kanseri Taramaları ve Mide Kanserinden Korunma. Ankara Medical Journal 12 4 195–198.
IEEE M. Alacalı, “Mide Kanseri, Mide Kanseri Taramaları ve Mide Kanserinden Korunma”, Ankara Med J, c. 12, sy. 4, ss. 195–198, 2012.
ISNAD Alacalı, Mehmet. “Mide Kanseri, Mide Kanseri Taramaları Ve Mide Kanserinden Korunma”. Ankara Medical Journal 12/4 (Nisan 2012), 195-198.
JAMA Alacalı M. Mide Kanseri, Mide Kanseri Taramaları ve Mide Kanserinden Korunma. Ankara Med J. 2012;12:195–198.
MLA Alacalı, Mehmet. “Mide Kanseri, Mide Kanseri Taramaları Ve Mide Kanserinden Korunma”. Ankara Medical Journal, c. 12, sy. 4, 2012, ss. 195-8.
Vancouver Alacalı M. Mide Kanseri, Mide Kanseri Taramaları ve Mide Kanserinden Korunma. Ankara Med J. 2012;12(4):195-8.